|Consensus development conference on antipsychotic drugs and obesity and diabetes|
American Diabetes Association
Diabetes care 27 (2), 596-601, 2004
|Practice guideline for the treatment of patients with borderline personality disorder|
American Psychiatric Association
American Psychiatric Pub, 2001
|Functional hypofrontality and working memory dysfunction in schizophrenia|
CS Carter, W Perlstein, R Ganguli, J Brar, M Mintun, JD Cohen
American Journal of Psychiatry 155 (9), 1285-1287, 1998
|Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network|
S Gulsuner, T Walsh, AC Watts, MK Lee, AM Thornton, S Casadei, ...
Cell 154 (3), 518-529, 2013
|Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder|
GD Pearlson, PE Barta, RE Powers, RR Menon, SS Richards, EH Aylward, ...
Biological psychiatry 41 (1), 1-14, 1997
|Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness|
R Ganguli, Z Yang, G Shurin, KNR Chengappa, JS Brar, AV Gubbi, ...
Psychiatry research 51 (1), 1-10, 1994
|Bidirectional interaction between the central nervous system and the immune system|
BS Rabin, S Cohen, R Ganguli, DT Lysle, JE Cunnick
Crit Rev Immunol 9 (4), 279-312, 1989
|Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: a candidate for schizophrenia and bipolar disorder?|
KG Chandy, E Fantino, O Wittekindt, K Kalman, LL Tong, TH Ho, ...
Molecular psychiatry 3 (1), 32-37, 1998
|Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients: the influence of age at onset and negative symptoms|
R Ganguli, JS Brar, KNR Chengappa, M DeLeo, ZW Yang, G Shurin, ...
Archives of general psychiatry 52 (8), 668-672, 1995
|Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison|
JM Kane, SR Marder, NR Schooler, WC Wirshing, D Umbricht, RW Baker, ...
Archives of General Psychiatry 58 (10), 965-972, 2001
|Electroencephalographic sleep in young, never-medicated schizophrenics: a comparison with delusional and nondelusional depressives and with healthy controls|
R Ganguli, CF Reynolds, DJ Kupfer
Archives of General Psychiatry 44 (1), 36-44, 1987
|Nutritional assessment of patients with schizophrenia: a preliminary study|
M Strassnig, JS Brar, R Ganguli
Schizophrenia Bulletin 29 (2), 393-397, 2003
|Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder.|
JS Brar, R Ganguli, G Pandina, I Turkoz, S Berry, R Mahmoud
Journal of Clinical Psychiatry 66 (2), 205-212, 2005
|Web-based psychoeducational intervention for persons with schizophrenia and their supporters: one-year outcomes|
AJ Rotondi, CM Anderson, GL Haas, SM Eack, MB Spring, R Ganguli, ...
Psychiatric Services 61 (11), 1099-1105, 2010
|Autoimmunity in schizophrenia: a review of recent findings|
R Ganguli, JS Brar, KN Roy Chengappa, ZW Yang, VL Nimgaonkar, ...
Annals of medicine 25 (5), 489-496, 1993
|Weight gain associated with antipsychotic drugs|
Journal of Clinical Psychiatry 60, 20-24, 1999
|Body mass index and quality of life in community-dwelling patients with schizophrenia|
M Strassnig, JS Brar, R Ganguli
Schizophrenia research 62 (1-2), 73-76, 2003
|Clinical and laboratory evidence of autoimmunity in acute schizophrenia|
R Ganguli, BS Rabin, RH Kelly, M Lyte, U Ragu
Annals of the New York Academy of Sciences 496 (1), 676-685, 1987
|Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects|
R Ganguli, BS Rabin
Archives of General Psychiatry 46 (3), 292-292, 1989
|Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis|
M Strassnig, J Miewald, M Keshavan, R Ganguli
Schizophrenia research 93 (1-3), 90-98, 2007